{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:47:24Z","timestamp":1794858444331,"version":"4.9.1"},"reference-count":298,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.waojou.2022.100640","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T19:07:25Z","timestamp":1654024045000},"page":"100640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Standards for practical intravenous rapid drug desensitization &amp; delabeling: A WAO committee statement"],"prefix":"10.1016","volume":"15","author":[{"given":"Emilio","family":"Alvarez-Cuesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3358-3578","authenticated-orcid":false,"given":"Ricardo","family":"Madrigal-Burgaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana D.","family":"Broyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cuesta-Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonieta","family":"Guzman-Melendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Maciag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Ansotegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Runa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Angel-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pilar","family":"Berges-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Bernal-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Cardona Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christoph","family":"Caubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Seok","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Ensina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manana","family":"Chikhladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Mirela","family":"Chiriac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene Heise","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gomez Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gonzalez Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ivancevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Ryun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merin","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Larco Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Latour-Staffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Macy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Jorgen","family":"Malling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Maspero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobalina","family":"Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Rodriguez-Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sanchez-Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Kase","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ure\u00f1a-Tavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco L.","family":"Valluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Volcheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2022.100640_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/all.14810","article-title":"Medical algorithm: diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy","author":"Madrigal-Burgaleta","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaip.2018.07.031","article-title":"A\u00a0large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents","volume":"7","author":"Madrigal-Burgaleta","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/all.12105","article-title":"Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment","volume":"68","author":"Madrigal-Burgaleta","year":"2013","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/all.12620","article-title":"Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization","volume":"70","author":"Alvarez-Cuesta","year":"2015","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib5","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.jaip.2020.08.005","article-title":"Controversies in allergy: chemotherapy reactions, desensitize or de-label?","volume":"8","author":"Hong","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2022.100640_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s40521-020-00238-y","article-title":"Importance of diagnostics prior to desensitization in new drug hypersensitivity: chemotherapeutics and biologicals","author":"Madrigal-Burgaleta","year":"2020","journal-title":"Curr Treat Options Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.18176\/jiaci.0425","article-title":"Does rapid drug desensitization to chemotherapy affect survival outcomes","volume":"30","author":"Berges-Gimeno","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib8","article-title":"Chemotherapy in mastocytosis: administration issues, hypersensitivity, and rapid drug desensitization","volume":"27","author":"Solano-Solares","year":"2017","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib9","first-page":"1356","article-title":"Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures","volume":"6","author":"Lopez-Gonzalez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jaci.2014.09.045","article-title":"Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations: to the editor","volume":"135","author":"Ure\u00f1a-Tavera","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib11","first-page":"435","article-title":"Desensitizing oxaliplatin-induced fever: a case report","volume":"23","author":"Madrigal-Burgaleta","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jaip.2013.12.011","article-title":"Successful rapid desensitization to methylprednisolone sodium hemisuccinate: a case report","volume":"2","author":"Angel-Pereira","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.waojou.2022.100640_bib13","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/all.14061","article-title":"Recent developments and highlights in\u00a0drug\u00a0hypersensitivity","volume":"74","author":"Mayorga","year":"2019","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.waojou.2022.100640_bib14","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1111\/all.14603","article-title":"Advances and novel developments in drug hypersensitivity diagnosis","volume":"75","author":"Ariza","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib15","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/all.12929","article-title":"Drug allergy passport and other documentation for patients with drug hypersensitivity \u2013 an ENDA\/EAACI Drug Allergy Interest Group Position Paper","volume":"71","author":"Brockow","year":"2016","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/all.13335","article-title":"What can we learn in drug allergy management from World Health Organization's International Classifications?","volume":"73","author":"Tanno","year":"2018","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib17","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/all.14468","article-title":"Global implementation of the World Health Organization's International Classification of Diseases (ICD)-11: the allergic and hypersensitivity conditions model","volume":"75","author":"Tanno","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International Consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaip.2020.08.002","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: general concepts","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib20","article-title":"International Consensus (ICON): allergic reactions to vaccines","volume":"9","author":"Dreskin","year":"2016","journal-title":"World Allergy Organ J"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaip.2020.08.001","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: introduction","volume":"8","author":"Fleisher","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib22","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jaip.2020.02.013","article-title":"Endophenotyping oxaliplatin hypersensitivity: personalizing desensitization to the atypical platin","volume":"8","author":"Silver","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes","volume":"142","author":"Isabwe","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10167","key":"10.1016\/j.waojou.2022.100640_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2022.100640_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.572863","article-title":"Rituximab hypersensitivity: from clinical presentation to management","volume":"11","author":"Fouda","year":"2020","journal-title":"Front Pharmacol"},{"issue":"July","key":"10.1016\/j.waojou.2022.100640_bib26","first-page":"1","article-title":"Interleukin-6: a novel biomarker for monoclonal antibody and chemotherapy-associated hypersensitivity confirms a cytokine release syndrome phenotype-endotype association","author":"Jakubovic","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anai.2019.05.010","article-title":"Drug allergy: veni, vidi, vici\u2014come, understand, and delabel, avoid, or desensitize","volume":"123","author":"Castells","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib28","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/all.13408","article-title":"The urgent need for a harmonized severity scoring system for acute allergic reactions","volume":"73","author":"Muraro","year":"2018","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib29","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2018.10.037","article-title":"Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions","volume":"152","author":"Vetter","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.waojou.2022.100640_bib31","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1365-2222.2011.03825.x","article-title":"Desensitization regimens for drug allergy: state of the art in the 21st century","volume":"41","author":"Liu","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: in\u00a0vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib35","first-page":"1","article-title":"Pilot experience using drug provocation testing for the study of hypersensitivity to chemotherapy and biological agents","volume":"31","author":"Marti-Garrido","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib36","article-title":"Delabeling patients from chemotherapy and biologics allergy: implementing drug provocation testing","author":"V\u00e1zquez-Revuelta","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.anai.2015.07.017","article-title":"Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy","volume":"115","author":"Wang","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib38","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaip.2017.08.025","article-title":"Utility of risk stratification for paclitaxel hypersensitivity reactions","volume":"6","author":"Otani","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaip.2017.03.015","article-title":"Immediate hypersensitivity reaction to chemotherapeutic agents","volume":"5","author":"Giavina-Bianchi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2222.2008.03155.x","article-title":"BSACI guidelines for the management of drug allergy","volume":"39","author":"Mirakian","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2022.100640_bib41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/all.15113","article-title":"Hypersensitivity reactions to chemotherapy: an EAACI position paper","volume":"77","author":"Pagani","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2022.100640_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/all.14984","article-title":"Hypersensitivity reactions to biologicals: an EAACI position paper","volume":"77","author":"Bavbek","year":"2022","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/all.14432","article-title":"Diagnosis and treatment of drug hypersensitivity reactions to biologicals: medical algorithm","author":"Yang","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaip.2016.12.001","article-title":"Current knowledge and management of hypersensitivity reactions to monoclonal antibodies","volume":"5","author":"Picard","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2000.18.1.102","article-title":"Paclitaxel-associated hypersensitivity reactions: experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer Center","volume":"18","author":"Markman","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2016.06.022","article-title":"Reactions to rituximab in an outpatient infusion center: a 5-year review","volume":"5","author":"Levin","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jclinpath-2019-206157","article-title":"Empty mast cell syndrome: fallacy or fact?","volume":"73","author":"Mohamed","year":"2020","journal-title":"J\u00a0Clin Pathol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1081-1206(10)61803-0","article-title":"Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"90","author":"Berges-Gimeno","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2015.10.039","article-title":"Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions","volume":"137","author":"Picard","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib51","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib52","first-page":"261","article-title":"Acute infusion reactions to chemotherapeutic drugs: a single institute experience","volume":"18","author":"Muallaoglu","year":"2013","journal-title":"J\u00a0BUON"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1756-9966-30-93","article-title":"Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS","volume":"30","author":"Kadoyama","year":"2011","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.waojou.2022.100640_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/207084","article-title":"Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review","volume":"2010","author":"Makrilia","year":"2010","journal-title":"Met Based Drugs"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2009.08.002","article-title":"A\u00a0safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity","volume":"8","author":"Legere","year":"2009","journal-title":"J\u00a0Cyst Fibros"},{"issue":"Nov","key":"10.1016\/j.waojou.2022.100640_bib56","first-page":"1","article-title":"Drug hypersensitivity and anaphylaxis in cancer and chronic inflammatory diseases: the role of desensitizations","volume":"8","author":"Castells","year":"2017","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib57","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jjco\/hyp070","article-title":"Allergic reactions to oxaliplatin in a single institute in Japan","volume":"39","author":"Ichikawa","year":"2009","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib58","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity \u2013 a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib59","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jaip.2018.12.010","article-title":"Platin chemotherapy hypersensitivity reactions: expanding the scope of practice and improving care","volume":"7","author":"Levin","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib60","first-page":"2045","article-title":"Readministration of platinum agents in recurrent ovarian cancer patients who developed hypersensitivity reactions to carboplatin","volume":"33","author":"Narui","year":"2019","journal-title":"In\u00a0Vivo"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaip.2015.12.019","article-title":"Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies","volume":"4","author":"Sloane","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061316","article-title":"Drug hypersensitivity and desensitizations: mechanisms and new approaches","volume":"18","author":"de las Vecillas S\u00e1nchez","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"December","key":"10.1016\/j.waojou.2022.100640_bib63","first-page":"1","article-title":"Mechanisms of drug desensitization: not only mast cells","volume":"11","author":"Vultaggio","year":"2020","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib64","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions \u2013 an EAACI position paper of the Drug Allergy Interest Group","volume":"68","author":"Scherer","year":"2013","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib65","first-page":"213","article-title":"Oxaliplatin immune-induced syndrome occurs with cumulative administration and rechallenge: single institution series and systematic review study","volume":"15","author":"Bencardino","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.waojou.2022.100640_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.03.054","article-title":"Reintroduction of antituberculous drugs in patients with antituberculous drug-related drug reaction with eosinophilia and systemic symptoms","author":"Oh","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaip.2017.02.014","article-title":"Practical management of antibiotic hypersensitivity in 2017","volume":"5","author":"Macy","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib68","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/eji.201040810","article-title":"Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting Fc\u03b5RI internalization","volume":"41","author":"del Carmen Sancho-Serra","year":"2011","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000068374","article-title":"Induction of basophil desensitization in physiological medium: enhancement after IgE-dependent upregulation of surface IgE binding on basophils","volume":"130","author":"Komiya","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib70","first-page":"75","article-title":"Management of drug allergy \u2013 an update","volume":"70","author":"Yamaguchi","year":"2021","journal-title":"Jpn J Allergol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib71","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)61136-2","article-title":"Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen","volume":"94","author":"Morales","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib72","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2222.1995.tb00033.x","article-title":"Challenge of mast cells with increasing amounts of antigen induces desensitization","volume":"25","author":"Shalit","year":"1995","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1398-9995.1998.tb03768.x","article-title":"Responsiveness of human skin mast cells to repeated activation: an in\u00a0vitro study","volume":"53","author":"Rubinchik","year":"1998","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib74","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jaip.2017.08.004","article-title":"Rituximab hypersensitivity: evaluation, desensitization, and potential mechanisms","volume":"5","author":"Wong","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/ped.2015.0615","article-title":"Rituximab desensitization in pediatric patients: results of a case series","volume":"29","author":"Dilley","year":"2016","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaip.2018.07.037","article-title":"Controversies in drug allergy: drug allergy pathways","volume":"7","author":"Chiriac","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2018.07.051","article-title":"Controversies in drug allergy: beta-lactam hypersensitivity testing","volume":"7","author":"Torres","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib78","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.bja.2019.03.018","article-title":"The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status","volume":"123","author":"Garvey","year":"2019","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaip.2018.06.030","article-title":"Controversies in drug allergy: radiographic contrast media","volume":"7","author":"S\u00e1nchez-Borges","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/all.13848","article-title":"The challenge of de-labeling penicillin allergy","volume":"75","author":"Stone","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib81","article-title":"The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study","author":"Chua","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib82","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.jaip.2020.07.046","article-title":"Positioning drug allergy delabeling as a critical tool for precision medicine, quality improvement, and public health","volume":"8","author":"Blumenthal","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib83","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaip.2019.11.035","article-title":"Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: a retrospective population-based study","volume":"8","author":"Liang","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2022.100640_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.02.005","article-title":"Drug allergy labels lost in translation: from patient to charts and backwards","author":"Ramsey","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib85","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.anai.2019.12.016","article-title":"Addressing the epidemic of antibiotic \u201callergy\u201d over-diagnosis","volume":"124","author":"Macy","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib86","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jaip.2019.04.014","article-title":"Large health system databases and drug hypersensitivity","volume":"7","author":"Chiriac","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2022.100640_bib87","series-title":"Harvard Business Essentials: Crisis Management: Master the Skills to Prevent Disasters","year":"2004"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib88","first-page":"1483","article-title":"Rapid desensitization to chemotherapy and monoclonal antibodies is effective and safe. Reply","volume":"68","author":"Alvarez-Cuesta","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2022.100640_bib89","series-title":"Alergia e Intolerancia Alimentaria","first-page":"413","article-title":"\u00c1rea de procedimientos alergol\u00f3gicos, diagn\u00f3sticos y terap\u00e9uticos en el siglo XXI: propuesta de un modelo est\u00e1ndar","author":"Alvarez-Cuesta","year":"2015"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib90","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.anai.2018.09.455","article-title":"New role for the modern allergist in drug allergy: assess, diagnose, and de-label","volume":"121","author":"Castells","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib91","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/all.13820","article-title":"An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions","volume":"74","author":"Garvey","year":"2019","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-4491-11-19","article-title":"Ten principles of good interdisciplinary team work","volume":"11","author":"Nancarrow","year":"2013","journal-title":"Hum Resour Health"},{"key":"10.1016\/j.waojou.2022.100640_bib93","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JMDH.S117945","article-title":"Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature","volume":"11","author":"Darzi","year":"2018","journal-title":"J\u00a0Multidiscip Healthc"},{"key":"10.1016\/j.waojou.2022.100640_bib94","series-title":"Guideline for Good Clinical Practice E6(R2)","author":"European Medicines Agency","year":"2018"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib95","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaip.2014.04.010","article-title":"Management of hypersensitivity reactions to carboplatin and paclitaxel in an outpatient oncology infusion center: a 5-year review","volume":"2","author":"Banerji","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib96","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000355831","article-title":"Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions","volume":"85","author":"Park","year":"2013","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/gyno.1994.1098","article-title":"Death from anaphylaxis to cisplatin: a case report","volume":"53","author":"Zweizig","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2016.09.027","article-title":"Platinum desensitization in patients with carboplatin hypersensitivity: a single-institution retrospective study","volume":"144","author":"Altwerger","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib99","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10147-014-0731-1","article-title":"4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study","volume":"20","author":"Takase","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaci.2011.10.010","article-title":"A\u00a0protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions","volume":"129","author":"Patil","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5811\/westjem.2015.3.25337","article-title":"Epinephrine for anaphylaxis: underutilized and unavailable","volume":"16","author":"Dudley","year":"2015","journal-title":"West J Emerg Med"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib102","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/alr.21884","article-title":"Pitfalls in the use of epinephrine for anaphylaxis: patient and provider opportunities for improvement","volume":"7","author":"Cohen","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.waojou.2022.100640_bib103","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/JAA.S159400","article-title":"Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities","volume":"11","author":"Prince","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"issue":"1071","key":"10.1016\/j.waojou.2022.100640_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/postgradmedj-2013-132181","article-title":"Correct recognition and management of anaphylaxis: not much change over a decade","volume":"91","author":"Plumb","year":"2015","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib105","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2020.10.e40","article-title":"Physicians' knowledge regarding epinephrine underuse in anaphylaxis","volume":"10","author":"Pimentel-Hayashi","year":"2020","journal-title":"Asia Pac Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib106","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/mai.2001.119028","article-title":"Emergency department anaphylaxis: a review of 142 patients in a single year","volume":"108","author":"Brown","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib107","doi-asserted-by":"crossref","DOI":"10.1111\/cts.12266","article-title":"Evolution of multidisciplinary translational teams (MTTs): insights for accelerating Translational Innovations","volume":"8","author":"Wooten","year":"2015","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib108","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.joi.2013.10.006","article-title":"Understanding the assembly of interdisciplinary teams and its impact on performance","volume":"8","author":"Lungeanu","year":"2015","journal-title":"J\u00a0Informetr"},{"issue":"40","key":"10.1016\/j.waojou.2022.100640_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/jncimonographs\/lgq010","article-title":"The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality","volume":"2010","author":"Fennell","year":"2010","journal-title":"JNCI Monogr"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib110","first-page":"1","article-title":"Zero harm in health care","volume":"1","author":"Gandhi","year":"2020","journal-title":"NEJM Catal Innov Care Deliv"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib111","first-page":"1","article-title":"Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement","volume":"9","author":"Kowalski","year":"2016","journal-title":"World Allergy Organ J"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib112","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/all.12610","article-title":"Quality-of-life issues in survivors to anaphylactic\u00a0reactions to drugs","volume":"70","author":"Baiardini","year":"2015","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib113","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11136-015-1051-2","article-title":"Turkish version of the drug hypersensitivity quality of life questionnaire: assessment of reliability and validity","volume":"25","author":"Bavbek","year":"2016","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib114","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/intqhc\/mzy207","article-title":"Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire: a multi-center study","volume":"31","author":"Chongpison","year":"2019","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.anai.2010.12.014","article-title":"Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire","volume":"106","author":"Baiardini","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib116","first-page":"508","article-title":"Cross-cultural adaptation and linguistic validation of the Spanish version of the drug hypersensitivity quality of life questionnaire","volume":"23","author":"Gastaminza","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib117","series-title":"Shaping the Future; Crossing the Quality Chasm: A New Health System for the 21th Century","year":"2001"},{"key":"10.1016\/j.waojou.2022.100640_bib118","article-title":"Change from the inside out health care leaders taking the helm","volume":"313","author":"Berwick","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"issue":"June","key":"10.1016\/j.waojou.2022.100640_bib119","article-title":"Managing risks: a new framework","author":"Kaplan","year":"2012","journal-title":"Harv Bus Rev"},{"key":"10.1016\/j.waojou.2022.100640_bib120","first-page":"1","article-title":"Novel quality improvement method to reduce cost while improving the quality of patient care: retrospective observational study","author":"Mate","year":"2020","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.waojou.2022.100640_bib121","series-title":"Improving the Safety of Patients in England","author":"Berwick","year":"2013"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib122","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2013.08.011","article-title":"Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization","volume":"2","author":"Wong","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib123","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000107467","article-title":"Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin","volume":"145","author":"Pagani","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib124","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In\u00a0vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"71","author":"Mayorga","year":"2016","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib125","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","article-title":"Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management","volume":"123","author":"Hesterberg","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-015-0515-3","article-title":"Presentation and diagnosis of hypersensitivity to platinum drugs","volume":"15","author":"Caiado","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib127","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2020.04.017","article-title":"Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: outcomes and risk factors","volume":"125","author":"Caiado","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib129","first-page":"170","article-title":"Immunoglobulin E-mediated severe anaphylaxis to paclitaxel","volume":"20","author":"Garc\u00eda","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jjco\/hys006","article-title":"An experimental biological test to diagnose hypersensitivity reactions to carboplatin: new horizons for an old problem","volume":"42","author":"Pagani","year":"2012","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaip.2013.06.002","article-title":"Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy","volume":"1","author":"Caiado","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib132","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1248\/bpb.b12-00150","article-title":"Evaluation of basophil CD203c as a predictor of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer","volume":"35","author":"Iwamoto","year":"2012","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib133","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.clinthera.2016.04.034","article-title":"Clinical utility of basophil CD203c as a biomarker for predicting the timing of hypersensitivity reaction in carboplatin rechallenge: three case reports","volume":"38","author":"Iwamoto","year":"2016","journal-title":"Clin Therapeut"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib134","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaip.2016.11.006","article-title":"Basophil activation test is a relevant biomarker of the outcome of rapid desensitization in platinum compounds-allergy","volume":"5","author":"Giavina-Bianchi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib135","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jaci.2019.01.010","article-title":"Nanoallergen platform for detection of platin drug allergies","volume":"143","author":"Deak","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.waojou.2022.100640_bib136","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/all.14582","article-title":"Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma","volume":"75","author":"Breiteneder","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib137","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2021.02.012","article-title":"Non\u2013IgE-mediated anaphylaxis","volume":"147","author":"Cianferoni","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib138","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2021.02.013","article-title":"Mechanisms of human drug-induced anaphylaxis","volume":"147","author":"Bruhns","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib139","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaip.2015.07.003","article-title":"Skin testing in the evaluation and management of carboplatin-related hypersensitivity reactions","volume":"3","author":"Lax","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib140","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.iac.2014.04.008","article-title":"Hypersensitivity reactions to biologic agents","volume":"34","author":"Vultaggio","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3\u20134","key":"10.1016\/j.waojou.2022.100640_bib141","first-page":"227","article-title":"Rapid drug desensitization with biologics: a single-center experience with four biologics","volume":"171","author":"Bavbek","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib142","doi-asserted-by":"crossref","first-page":"468","DOI":"10.18176\/jiaci.0445","article-title":"Rapid drug desensitization with rituximab in 24 cases: a single-center experience","volume":"29","author":"G\u00f6rg\u00fcl\u00fc","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib143","doi-asserted-by":"crossref","first-page":"132","DOI":"10.18176\/jiaci.0031","article-title":"Successful desensitization to cetuximab in a patient with a positive skin test to cetuximab and specific IgE to alpha-gal","volume":"26","author":"Garc\u00eda-Menaya","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib144","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/eci.11.75","article-title":"Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies","volume":"8","author":"Hong","year":"2012","journal-title":"Expet Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/cea.12098","article-title":"Allergological in\u00a0vitro and in\u00a0vivo evaluation of patients with hypersensitivity reactions to infliximab","volume":"43","author":"Matucci","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib146","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000336839","article-title":"Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab","volume":"159","author":"Vultaggio","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib147","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1398-9995.2009.02280.x","article-title":"Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions","volume":"65","author":"Vultaggio","year":"2010","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib148","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaci.2014.12.1947","article-title":"The alpha-gal story: lessons learned from connecting the dots","volume":"135","author":"Steinke","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib149","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-\u03b1-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaip.2015.10.007","article-title":"Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization","volume":"4","author":"Gonz\u00e1lez-de-Olano","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.23329","article-title":"Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: in\u00a0vitro evaluation of rituximab hypersensitivity by basophil activation test","volume":"87","author":"Piva","year":"2012","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib152","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.alit.2016.09.002","article-title":"Rapid subcutaneous desensitization for treatment of hypersensitivity reactions to etanercept in two patients with positive basophil activation test","volume":"66","author":"de la Varga Mart\u00ednez","year":"2017","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib153","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jaip.2020.10.044","article-title":"Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions","volume":"9","author":"Barakat","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib154","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/all.12586","article-title":"In\u00a0vivo diagnosis of allergic diseases \u2013 allergen provocation tests","volume":"70","author":"Agache","year":"2015","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.waojou.2022.100640_bib156","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib157","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/jac\/dkw008","article-title":"Antimicrobial allergy \u201clabels\u201d drive inappropriate antimicrobial prescribing: lessons for stewardship","volume":"71","author":"Trubiano","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib158","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.clinthera.2017.09.012","article-title":"Impact of penicillin allergy on time to first dose of antimicrobial therapy and clinical outcomes","volume":"39","author":"Conway","year":"2017","journal-title":"Clin Therapeut"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib159","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2020.2227","article-title":"Association between penicillin allergy documentation and antibiotic use","volume":"180","author":"Blumenthal","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-014-0476-y","article-title":"Penicillin and beta-lactam allergy: epidemiology and diagnosis","volume":"14","author":"Macy","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"24","key":"10.1016\/j.waojou.2022.100640_bib161","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMra1807761","article-title":"Penicillin allergy","volume":"381","author":"Castells","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib162","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jama.2017.6510","article-title":"Penicillin allergy is not necessarily forever","volume":"318","author":"Trubiano","year":"2017","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib163","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/cix244","article-title":"Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation","volume":"65","author":"Trubiano","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib164","first-page":"3209","article-title":"Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer","volume":"73","author":"Trubiano","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/ice.2019.50","article-title":"Outcomes from an inpatient beta-lactam allergy guideline across a large US health system","volume":"40","author":"Blumenthal","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib166","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/cid\/cix512","article-title":"Point-of-care \u03b2-lactam allergy skin testing by antimicrobial stewardship programs: a pragmatic multicenter prospective evaluation","volume":"65","author":"Leis","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib167","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaip.2017.11.012","article-title":"Use of a penicillin allergy screening algorithm and penicillin skin testing for transitioning hospitalized patients to first-line antibiotic therapy","volume":"6","author":"Ramsey","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib168","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/all.13168","article-title":"Clinical outcomes following inpatient penicillin allergy testing: a systematic review and meta-analysis","volume":"72","author":"Sacco","year":"2017","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib169","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.anai.2018.11.008","article-title":"Inpatient \u03b2-lactam test-dose protocol and antimicrobial stewardship in patients with a history of penicillin allergy","volume":"122","author":"Sacco","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib170","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.jaip.2019.05.051","article-title":"Beta-lactam and sulfonamide allergy testing should be a standard of care in immunocompromised hosts","volume":"7","author":"Trubiano","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib171","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/QCO.0000000000000006","article-title":"Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to \u201cde-labeling\u201d","volume":"26","author":"Trubiano","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib172","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib173","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1592\/phco.31.8.736","article-title":"Assessment of the validity of reported antibiotic allergic reactions in pediatric patients","volume":"31","author":"Miller","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib174","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib175","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jaip.2018.07.048","article-title":"Pathways to improved antibiotic allergy and antimicrobial stewardship practice: the validation of a beta-lactam antibiotic allergy assessment tool","volume":"7","author":"Devchand","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib176","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/jac\/dkz082","article-title":"Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention","volume":"74","author":"Devchand","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib177","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib178","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jaip.2019.09.025","article-title":"Multicenter Australian study to determine criteria for low- and high-risk penicillin testing in outpatients","volume":"8","author":"Stevenson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib179","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jaip.2019.03.015","article-title":"Identifying low-risk beta-lactam allergy patients in a UK Tertiary Centre","volume":"7","author":"Siew","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaip.2017.04.045","article-title":"Designing predictive models for beta-lactam allergy using the drug allergy and hypersensitivity database","volume":"6","author":"Chiriac","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.waojou.2022.100640_bib181","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1164\/rccm.202001-0089LE","article-title":"Risk-stratified management to remove low-risk penicillin allergy labels in the ICU","volume":"201","author":"Stone","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib182","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-019-0854-6","article-title":"Evaluating penicillin allergies without skin testing","volume":"19","author":"Banks","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.waojou.2022.100640_bib183","doi-asserted-by":"crossref","DOI":"10.1080\/14787210.2020.1792775","article-title":"The democratisation of de-labelling: a review of direct oral challenge in adults with low-risk penicillin allergy","author":"Rose","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.waojou.2022.100640_bib184","article-title":"Penicillin allergy testing is cost-saving: an economic evaluation study","author":"Sousa-Pinto","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib185","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/ACI.0000000000000651","article-title":"The economics of drug allergy","volume":"20","author":"Mattingly","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib186","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.anai.2020.03.012","article-title":"Children with reported penicillin allergy: public health impact and safety of delabeling","volume":"124","author":"Vyles","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib187","doi-asserted-by":"crossref","DOI":"10.1111\/all.14800","article-title":"Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams","author":"Prieto","year":"2021","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib188","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.anai.2020.05.004","article-title":"Direct amoxicillin challenge without preliminary skin testing for pediatric patients with penicillin allergy labels","volume":"125","author":"Wang","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib189","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/cea.13443","article-title":"Should testing be initiated prior to amoxicillin challenge in children?","volume":"49","author":"Abrams","year":"2019","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib191","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cea.12468","article-title":"Management of allergy to penicillins and other beta-lactams","volume":"45","author":"Mirakian","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib192","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial","volume":"7","author":"Mustafa","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib193","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jaip.2019.06.001","article-title":"Cephalosporin allergy: current understanding and future challenges","volume":"7","author":"Khan","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib194","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/all.12390","article-title":"Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins","volume":"69","author":"Romano","year":"2014","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib195","article-title":"Testing strategies and predictors for evaluating immediate and delayed reactions to cephalosporins","author":"Stone","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib196","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jaip.2018.01.020","article-title":"Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins","volume":"6","author":"Romano","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib197","doi-asserted-by":"crossref","DOI":"10.1186\/s13601-020-00368-1","article-title":"Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes","volume":"10","author":"Bogas","year":"2020","journal-title":"Clin Transl Allergy"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib198","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"17","key":"10.1016\/j.waojou.2022.100640_bib199","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2022.100640_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.12.420","article-title":"Safety, efficacy and effectiveness of delabeling in patients with multiple drug allergy labels","author":"Vethody","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib201","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Weiss","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib202","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaip.2019.07.003","article-title":"Oral challenge with trimethoprim-sulfamethoxazole in patients with \u201csulfa\u201d antibiotic allergy","volume":"8","author":"Krantz","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7542","key":"10.1016\/j.waojou.2022.100640_bib203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.waojou.2022.100640_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.12.066","article-title":"Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic","author":"Krantz","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/cea.12099","article-title":"Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved","volume":"43","author":"Blanca-L\u00f3pez","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib206","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.jaip.2020.04.051","article-title":"Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones","volume":"8","author":"Do\u00f1a","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib207","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib208","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/ai.1994.v94.a55251","article-title":"Vancomycin hypersensitivity: synergism with narcotics and \u201cdesensitization\u201d by a rapid continuous intravenous protocol","volume":"94","author":"Wong","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib209","first-page":"354","article-title":"Preventing occupational exposures to antineoplastic drugs in health care settings","volume":"56","author":"Connor","year":"2006","journal-title":"CA \u2013 Cancer J Clin"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaip.2016.07.010","article-title":"Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer","volume":"5","author":"Lax","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib211","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.iac.2017.06.003","article-title":"Platinum chemotherapy hypersensitivity: prevalence and management","volume":"37","author":"Otani","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.18176\/jiaci.0070","article-title":"Experience with rapid desensitization to chemotherapy in a type B hospital","volume":"26","author":"Borras","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib213","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaip.2016.05.015","article-title":"A\u00a0modified protocol for rapid desensitization to chemotherapy agents","volume":"4","author":"Vidal","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib214","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jaip.2017.11.033","article-title":"Outcome of 490 desensitizations to chemotherapy drugs with a rapid one-solution protocol","volume":"6","author":"P\u00e9rez-Rodr\u00edguez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00280-018-3662-0","article-title":"A\u00a0new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity","volume":"82","author":"Chung","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib216","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jaip.2019.10.014","article-title":"A\u00a0one-bag rapid desensitization protocol for paclitaxel hypersensitivity: a noninferior alternative to a multi-bag rapid desensitization protocol","volume":"8","author":"Lee","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib217","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/1078155218772885","article-title":"Stability of carboplatin infusion solutions used in desensitization protocol","volume":"25","author":"V\u00e1zquez-Sa\u00e1nchez","year":"2019","journal-title":"J\u00a0Oncol Pharm Pract"},{"key":"10.1016\/j.waojou.2022.100640_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.06.024","article-title":"One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: a five-year experience","author":"Sala-Cunill","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib219","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s11096-015-0136-x","article-title":"Desensitization to rituximab in a multidisciplinary setting","volume":"37","author":"Amor\u00f3s-Reboredo","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5114\/reum.2020.93510","article-title":"Desensitization to biological agents used in rheumatology","volume":"58","author":"Makowska","year":"2020","journal-title":"Reumatologia"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib221","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jaip.2016.05.013","article-title":"Hypersensitivity reactions to rituximab: 53 successful desensitizations in 7 patients with severe, near-fatal reactions","volume":"4","author":"Lebel","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib222","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1081-1206(10)60247-5","article-title":"Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization","volume":"102","author":"Breslow","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib224","article-title":"Assessment of antihistamines and corticosteroids as\u00a0premedication in rapid drug desensitization to paclitaxel:\u00a0outcomes in 155 procedures","volume":"6","author":"Lopez-Gonzalez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib225","doi-asserted-by":"crossref","DOI":"10.1186\/s13601-020-0309-0","article-title":"Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study","volume":"10","author":"Oude Elberink","year":"2020","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.18176\/jiaci.0496","article-title":"Successful desensitization to oxaliplatin after a single initial dose of omalizumab in a patient with elevated IgE levels","volume":"30","author":"Penella","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib227","doi-asserted-by":"crossref","first-page":"298","DOI":"10.18176\/jiaci.0499","article-title":"Usefulness of omalizumab in rapid drug desensitization in patients with severe anaphylaxis induced by carboplatin: open questions","volume":"30","author":"S\u00e1nchez-Morillas","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib228","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18176\/jiaci.0326","article-title":"Unexpected anaphylaxis after completing a desensitization protocol to oxaliplatin: successful adjuvant use of omalizumab","volume":"29","author":"Prieto-Garc\u00eda","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib229","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaip.2013.08.009","article-title":"Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels","volume":"2","author":"Ojaimi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/ACI.0000000000000648","article-title":"Omalizumab and other biologics in drug desensitization","volume":"20","author":"Fernandez","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib231","doi-asserted-by":"crossref","first-page":"225","DOI":"10.18176\/jiaci.0177","volume":"27","author":"Martorell","year":"2017","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib232","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/pai.13049","article-title":"Anaphylaxis after Elosulfase A infusion: omalizumab as coadjuvant for enzyme replacement therapy desensitization","volume":"30","author":"Arroabarren","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib233","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaip.2015.11.012","article-title":"Diagnosis and management of infusion-related hypersensitivity reactions to enzyme replacement therapy for lysosomal diseases: the role of desensitization","volume":"4","author":"Aranda","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib234","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11882-011-0239-y","article-title":"Management of multiple drug allergies in children","volume":"12","author":"Dioun","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib235","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2015.11.015","article-title":"Anaphylaxis in children and adolescents: the European Anaphylaxis Registry","volume":"137","author":"Grabenhenrich","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib236","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.0306-5251.2001.01407.x","article-title":"Incidence of adverse drug reactions in paediatric in\/out-patients: a systematic review and meta-analysis of prospective studies","volume":"52","author":"Impicciatore","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib237","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999\u20132010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib238","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-019-0841-y","article-title":"Pediatric drug hypersensitivity","volume":"19","author":"Rukasin","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib239","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijantimicag.2016.08.001","article-title":"Allergy to antibiotics in children: an overestimated problem","volume":"48","author":"Esposito","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib240","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-2497","article-title":"Antibiotic allergy in pediatrics","volume":"141","author":"Norton","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib241","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib242","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.iac.2004.03.008","article-title":"Drug desensitization","volume":"24","author":"Solensky","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib243","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0091-6749(98)70061-2","article-title":"IgE-mediated allergy and desensitization to factor IX in hemophilia B","volume":"102","author":"Dioun","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib244","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaip.2013.11.007","article-title":"Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children","volume":"2","author":"Hong","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib245","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.jaip.2018.04.004","article-title":"Successful rapid oral clindamycin desensitization in a pediatric patient","volume":"6","author":"Esty","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib246","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00431-010-1236-1","article-title":"Clinical practice: drug desensitization in children","volume":"169","author":"De Groot","year":"2010","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib247","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1081-1206(10)61778-4","article-title":"Antibiotic desensitization for the allergic patient: 5 years of experience and practice","volume":"92","author":"Turvey","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib248","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anai.2016.05.013","article-title":"Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist","volume":"117","author":"Khan","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib249","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26306","article-title":"Methotrexate hypersensitivity reactions in pediatrics: evaluation and management","volume":"64","author":"Dilley","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib250","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/pai.13059","article-title":"A\u00a0case series of pediatric oncology patients undergoing successful rapid etoposide desensitization","volume":"30","author":"Wright","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2022.100640_bib251","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/08880018.2019.1634778","article-title":"PEGylated E.\u00a0coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability","volume":"36","author":"Verma","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib252","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/ACI.0b013e3283464bcd","article-title":"Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management","volume":"11","author":"Vultaggio","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib253","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.acap.2016.11.004","article-title":"Parent-reported penicillin allergy symptoms in the pediatric emergency department","volume":"17","author":"Vyles","year":"2017","journal-title":"Acad Pediatr"},{"issue":"7","key":"10.1016\/j.waojou.2022.100640_bib254","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cid\/ciw462","article-title":"Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study","volume":"63","author":"Macfadden","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib255","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0471","article-title":"Allergy testing in children with low-risk penicillin allergy symptoms","volume":"140","author":"Vyles","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib256","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2222.2007.02870.x","article-title":"Drug allergy claims in children: from self-reporting to confirmed diagnosis","volume":"38","author":"Rebelo Gomes","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib257","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2500\/aap.2014.35.3744","article-title":"The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience","volume":"35","author":"Vezir","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib258","first-page":"2738","article-title":"Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses","volume":"7","author":"Picard","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib259","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.anai.2020.02.007","article-title":"Hypersensitivity to tetracyclines: skin testing, graded challenge, and desensitization regimens","volume":"124","author":"Maciag","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.18176\/jiaci.0314","article-title":"Successful slow desensitization to tocilizumab in a 15-year-old patient","volume":"28","author":"Cansever","year":"2018","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib261","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaci.2013.02.004","article-title":"Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: increase in number of Treg cells after desensitization","volume":"132","author":"Aydogan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib262","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00054725-200102000-00005","article-title":"Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction","volume":"7","author":"Van Kruiningen","year":"2001","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib263","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/14740330903446936","article-title":"Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity","volume":"9","author":"Limsuwan","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib264","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00228-013-1546-0","article-title":"Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer","volume":"69","author":"Ruggiero","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2013.11.003","article-title":"Successful desensitization to brentuximab vedotin after anaphylaxis","volume":"14","author":"O'connell","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib266","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pbc.25686","article-title":"Carboplatin hypersensitivity reactions in pediatric low grade glioma are protocol specific and desensitization shows poor efficacy","volume":"63","author":"Dodgshun","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib267","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/FTD.0b013e3181dbdf8e","article-title":"Carboplatin hypersensitivity and desensitization in an infant","volume":"32","author":"Montiel Herrera","year":"2010","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib268","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1034\/j.1399-6576.2001.451005.x","article-title":"Danish Anaesthesia Allergy Centre \u2013 preliminary results","volume":"45","author":"Garvey","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib269","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1398-9995.2011.02661.x","article-title":"The in\u00a0vitro diagnosis of drug allergy: status and perspectives","volume":"66","author":"Ebo","year":"2011","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"45","key":"10.1016\/j.waojou.2022.100640_bib270","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.2174\/1381612822666161107165917","article-title":"Cellular tests for the evaluation of drug hypersensitivity","volume":"22","author":"Ariza","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib271","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1398-9995.2006.01268.x","article-title":"Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate \u03b2-lactam allergy","volume":"62","author":"Fontaine","year":"2007","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib272","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2222.2009.03219.x","article-title":"Influence of total serum IgE levels on the in\u00a0vitro detection of \u03b2-lactams-specific IgE antibodies","volume":"39","author":"Vultaggio","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib273","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121857","article-title":"High serum \u03b2-lactams specific\/total IgE ratio is associated with immediate reactions to \u03b2-lactams antibiotics","volume":"10","author":"Vultaggio","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.waojou.2022.100640_bib274","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2012.11.017","article-title":"False-positive penicillin immunoassay: an unnoticed common problem","volume":"132","author":"Johansson","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.anai.2010.06.014","article-title":"Use of commercial anti-penicillin IgE fluorometric enzyme immunoassays to diagnose penicillin allergy","volume":"105","author":"MacY","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib276","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2222.2002.01305.x","article-title":"Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics","volume":"32","author":"Sanz","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib277","first-page":"278","article-title":"Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests","volume":"14","author":"Gamboa","year":"2004","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"11","key":"10.1016\/j.waojou.2022.100640_bib278","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/j.1365-2222.2004.02110.x","article-title":"The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams","volume":"34","author":"Torres","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib279","first-page":"91","article-title":"Diagnosis of immediate-type beta-lactam allergy in\u00a0vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study","volume":"19","author":"De Week","year":"2009","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2022.100640_bib280","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jaci.2019.11.036","article-title":"Design of an antigenic determinant of cefaclor: chemical structure\u2013IgE recognition relationship","volume":"145","author":"Mart\u00edn-Serrano","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib281","first-page":"473","article-title":"Diagnosis of clavulanic acid allergy using basophil activation and leukotriene release by basophils","volume":"18","author":"Longo","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100640_bib282","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaip.2017.08.009","article-title":"Use of the basophil activation test may reduce the need for drug provocation in amoxicillin-clavulanic allergy","volume":"6","author":"Salas","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.11.032","article-title":"Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions","volume":"125","author":"Torres","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2022.100640_bib284","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/all.13761","article-title":"Identification of an antigenic determinant of clavulanic acid responsible for IgE-mediated reactions","volume":"74","author":"Barbero","year":"2019","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib285","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaip.2016.08.016","article-title":"Diagnosing cefazolin hypersensitivity: lessons from dual-labeling flow cytometry","volume":"4","author":"Uyttebroek","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib286","first-page":"103","article-title":"In\u00a0vitro diagnosis of immediate allergic reactions to drugs: an update","volume":"20","author":"Mayorga","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib287","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1398-9995.2008.01713.x","article-title":"Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins","volume":"64","author":"Fern\u00e1ndez","year":"2009","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib288","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1398-9995.2008.01924.x","article-title":"Update on the evaluation of hypersensitivity reactions to betalactams","volume":"64","author":"Blanca","year":"2009","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib289","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1034\/j.1398-9995.2003.00280.x","article-title":"Diagnosis of immediate allergic reactions to beta-lactam antibiotics","volume":"58","author":"Torres","year":"2003","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100640_bib290","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaci.2005.10.032","article-title":"Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins","volume":"117","author":"Antunez","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib291","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1034\/j.1398-9995.2001.00995.x","article-title":"Clinical evaluation of Pharmacia CAP System\u2122 RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy","volume":"56","author":"Blanca","year":"2001","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib292","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1034\/j.1398-9995.2002.23832_10.x","article-title":"IgE antibodies to penicillin in skin test negative patients","volume":"57","author":"Torres","year":"2002","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100640_bib293","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1034\/j.1398-9995.2001.00089.x","article-title":"Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing","volume":"56","author":"Torres","year":"2001","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib294","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061222","article-title":"The value of in\u00a0vitro tests to diminish drug challenges","volume":"18","author":"Mayorga","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.waojou.2022.100640_bib295","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.14122","article-title":"Towards a more precise diagnosis of hypersensitivity to beta-lactams \u2014 an EAACI position paper","volume":"75","author":"Romano","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.waojou.2022.100640_bib296","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1111\/all.14298","article-title":"Characterization of amoxicillin and clavulanic acid specific T-cell clones from patients with immediate drug hypersensitivity","volume":"75","author":"Ariza","year":"2020","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib297","doi-asserted-by":"crossref","DOI":"10.1111\/all.14755","article-title":"Dendritic cells inclusion and cell-subset assessment improve flow-cytometry-based proliferation test in non-immediate drug hypersensitivity reactions","author":"Fernandez-Santamaria","year":"2021","journal-title":"Allergy \u2013 Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib298","doi-asserted-by":"crossref","DOI":"10.1097\/ACI.0000000000000821","article-title":"Drug allergy desensitization is not a unique recipe","author":"Madrigal-Burgaleta","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2022.100640_bib300","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2021.787537","article-title":"Safe Handling of Antineoplastic Drugs During Allergy Diagnostic Workup and Desensitization: A Single Experience\u00a0of the Allergy Department in a Tertiary Hospital","author":"Berges-Gimeno","year":"2022","journal-title":"Front. Allergy"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455122000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455122000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:45:13Z","timestamp":1761849913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455122000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":298,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1939455122000163"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2022.100640","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2022.100640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100640"}}